← News

ICH M15 is final, and every package now follows it

ICH M15 reached Step 4 in January 2026 and FDA published it as final guidance in June 2026. Every package we deliver now follows its framework.

ICH M15 reached Step 4 in January 2026, and FDA published it as final guidance in June 2026. It gives model-informed drug development a shared framework: a question of interest, a context of use, an assessment of model influence and of the consequence of a wrong decision, and the documentation that goes with them.

Each package we deliver now includes a model analysis plan approved before modeling starts, a model analysis report, a completed assessment table and a verification package.

Our plain-language guide to M15 sets out what changed and what to prepare before your next regulatory meeting.

Is this question in front of your program?

A 15-minute call is enough to tell whether modeling can move it. A fixed proposal follows within 48 hours.